| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 3 | 2 | |
| Treat side effects of another treatment | 2 | 0 | |
| Chronic inflammatory demyelinating polyneuropathy | 1 | 0 | |
| Mast cell activation syndrome | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 4 |